Top Banner
Skin Barrier Integrity and Microbiome-Mediated Immune Regulation and Dysregulation Author: Asad Zaidi Capstone Advisor: Mary Montgomery 5/6/2015
30
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Zaidi_Capstone

Skin Barrier Integrity and Microbiome-Mediated Immune

Regulation and Dysregulation

Author: Asad Zaidi

Capstone Advisor: Mary Montgomery

5/6/2015

Page 2: Zaidi_Capstone

Zaidi 2

ABSTRACT

Our skins are home to a whole host of commensal microorganisms. Since the skin is

the organ most in contact with the outside environment and the first immunological barrier,

the skin commensals help out by regulating both innate and adaptive immunity. However,

barrier defects in the skin can dramatically change the behavior of the microbiome from

protective and benign to inflammatory and pathogenic, leading to conditions such as atopic

dermatitis.

PREFACE

Eczema/atopic dermatitis is something that runs in my family. It is a condition

associated with immunity and the immune system. While I was initially looking for a

topic for my final paper for Immunology, I looked for mechanisms surrounding eczema.

We had just covered the gut microbiome in class and the concept fascinated me, so when

I discovered that eczema was also connected to the microbiome, I began my research.

The fact that studying the microbiota is so recent – I was literally finding a freshly

published article on the topic every few days – also kept my interest piqued; there is still

so much to discover!

BLURB

Maintenance of skin barrier integrity is key for positive regulation of skin

immunity by commensals. Compromised integrity can lead to dysregulation of skin

immunity by commensals and, ultimately, atopic dermatitis.

Page 3: Zaidi_Capstone

Zaidi 3

INTRODUCTION

One classic scientific fact used in many Biology classes to shock, amaze and

intrigue students is that roughly ninety percent of the cells that constitute the human body

contain microbial, rather than Homo sapiens, genetic material [1]. Although this idea has

quickly become assimilated into the mainstream body of ‘general knowledge’ this finding

is actually quite recent. It was not until the recent advances in metagenomics technology

and the rise of low-cost, high-throughput genetic sequencing techniques – techniques

such as 16S gene profiling (Fig 1) – that the realm of microorganisms living inside and

on the human body could extensively be explored and studied [2].

The Human Microbiome Project was launched in 2008 in an attempt to sequence

and profile all the microorganisms commonly found thriving alongside human cells in the

living human body [1]. What it discovered was a stunning array of microbial diversity

(Fig 2).

Such a staggeringly large number of non-human cells cannot simply be

bystanders in the human body, neither affecting nor being affected by the many bodily

functions and homeostatic processes occurring every instant. The microorganisms –

mostly bacteria of the four phyla Actinobacteria, Bacteroidetes, Firmicutes and

Proteobacteria along with viruses and fungi – that make up the microbiome [1] are both

specific and highly specialized for inhabiting the region of the body in which they are

found.

Niche specialization in a host organism involves not only being adapted to the

environment, but also being an asset for that particular bodily niche, so that there is an

incentive to being kept around. Thus, many microbes that are part of the microbiome are

Page 4: Zaidi_Capstone

Zaidi 4

described to have commensal relationships with their hosts, that is, a relationship between

two organisms where one of the two benefits from the relationship while the other

remains unaffected. However, it could be argued that, given the protection conferred by

certain prominent species that will be discussed in greater detail in this paper, some

relationships could be characterized as mutualistic, where both co-existing parties benefit

from the relationship [3]. Despite this, organisms that constitute the skin microbiome will

be referred solely to as ‘commensals’ in this paper to reflect the scientific community’s

consensus on how to label them.

As a large proportion of our bodies’ resources are spent on immunity, immune

function and modulation, it is logical for commensal microbes to ‘earn their keep’ by

initiating, regulating, catalyzing or assisting with these very processes. Indeed, the gut

microbiome has already been established as a key player in the immunity of the whole

body in general and in the gastrointestinal tract specifically [4]. The microbiome that has

only just begun to garner attention is the human skin microbiome.

THE SKIN MICROBIOME

The skin is the largest organ of the human body. It functions as a physical barrier,

forming the initial immunological threshold that both prevents the entry of pathogens and

potentially harmful substances as well as the loss of water and essential solutes [5]. It is a

complex, multi-layered surface riddled with invaginations, glands and hair follicles, all of

which provide a multitude of habitable niches with varied thickness, moisture content and

follicular density. It is estimated that every square inch of human skin is inhabited by

approximately 1 billion bacteria [6].

Page 5: Zaidi_Capstone

Zaidi 5

The microbiome of the human skin begins developing not long after birth. While

the skin of the fetus is considered to be mostly sterile in its mother’s uterus, passage

through the birth canal brings newborns into contact with bacterial communities that will

inevitably go on to form colonies. Domniquez-Bello et al. show that the mode of delivery

impacts the identities of bacteria that form the initial microbiome. This, in turn, also

impacts the health of the baby [7]. Neonates delivered vaginally have skin microbiomes

that resemble the vaginal microbiotas of their mothers, whereas neonates delivered via a

Caesarean section procedure have skin microbiomes more likely to be made up of the

types of bacteria found on the mother’s skin.

An infant’s skin microbiome is quite homogenous at first, evolving and showing

increasing diversity over time. A study conducted by Capone et al. observed how the

microbiome changed as infants grew. Swab samples were taken from 31 healthy infants,

each falling into one of three age groups based on infant skin maturation properties, and

from mothers who served as adult controls [8]. The study controlled for ethnicity by

using only Caucasian subjects and for variations in baby bathing methods by normalizing

the procedure volunteering mothers were to follow prior to the swab test. At least for the

first year, the microbiome is dissimilar to that of an adult, primarily due to that fact that

infants have more moisture in their skin, allowing the colonization of a proportionally

greater amount of Staphylococci bacteria. However, with age, the microbiome diversifies

and becomes more akin to that of an adult by the time the infant is 12-18 months of age

[8]. Once adulthood is reached, however, the microbiota becomes relatively less subject

to change.

Page 6: Zaidi_Capstone

Zaidi 6

Elizabeth Grice is one of the leading researchers of the human skin microbiome.

Her lab at the University of Pennsylvania Perelman School of Medicine, Department of

Dermatology has a keen interest in ‘leverag[ing] our understanding of microbiome-host

interactions to diagnose and treat skin disorders’ [9]. Grice et al., looking to profile the

bacterial diversity found in the microbiome of adult skin, discovered that interpersonal

variation was almost the same as intrapersonal variation when it came to bacterial

community membership and structure [6]. Analysis of microbial communities on the skin

of the palm showed that samples taken from either hand of the same individual shared

only 17% of their phylotypes1, whereas comparisons of samples taken from different

individuals showed only a 13% phylotype commonality [3]. However, microbial

communities at different body sites are almost uniformly dominated by the phyla

Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria [6]. Along the way, Grice

et al. made certain discoveries that could have an impact on how studies on the skin

microbiome are conducted. Skin samples acquired by swabbing, scraping and skin punch

were compared. 16S gene profiling of the samples showed that there was a great overlap

between the OTUs (operational taxonomic units) found using each method. This result

indicates that the use of invasive sampling methods is unnecessary. The study also found

a significant degree of comparability between the microbiota present on human skin and

that on murine ear skin, strengthening the case for mice as model organisms for the study

of the skin microbiome. The skin microbiota is relatively stable, with distinct anatomical

niches colonised by specific and specialised groups of microorganisms, as demonstrated

1 Phylotypes are groups that classify organisms based on observable similarities (morphology etc). These groups do not adhere to taxonomical hierarchy and, thus, the rank at which they describe groupings (species, phylum etc) can be circumstantially chosen.

Page 7: Zaidi_Capstone

Zaidi 7

by Grice and a colleague in another study [10]. The composition of the skin microbiota is

more determined by the body site niche (Fig 3) than one’s genetic fingerprint [3].

Examples of distinct body site niches include the glabella (skin between eyebrows

and above nose), the antecubital fossa (the elbow pit), and the interdigital web space (skin

between fingers). Skin regions with a higher density of sebaceous glands have a higher

content of surface lipids and, thus, are inviting habitats for lipophilic bacteria such as

Propionibacterium acnes [3]. This, to some extent, is why certain areas of the skin are

more prone to acne, a condition thought to be associated with the presence of P. acnes.

Microbes not typically found in these niches can usually only exist as transient flora,

temporarily colonising the niches before being driven away due to competition with the

more permanent residents [3].

This and similar findings suggest that the permanent residents of ecological body

niches of the skin have a stake in remaining where they are, but also points towards the

possibility that their existence may be beneficial to their human hosts. The skin

microbiome interacts not only with human skin but also with the environment and forms

a bridge between other microorganisms and human tissue [3].

IMMUNE MODULATION

The outermost layers of the skin are comprised of mostly keratinocytes. These

cells make up the water-proof barrier between bodily tissues and the environment. They,

along with sebaceous glands [11], also participate in innate immunity by secreting

antimicrobial peptides including catheclidin LL37 or beta-defensins. These molecules are

produced against highly conserved pathogenic antigens, typically found on

Page 8: Zaidi_Capstone

Zaidi 8

Staphylococcus aureus, Group A Streptococcus, and Escherichia coli [3]. Interestingly,

these compounds are not active against Staphylococcus epidermidis, possibly due to the

benefits of hosting S. epidermidis in the skin and resulting from the ‘resolution’ of an

evolutionary arms race between humans and S. epidermidis.

Evidence supporting this hypothesis lies in the production of a polymer called

Poly-N-acetylglucosamine (PNAG) by S. epidermidis. PNAG is primarily an adhesion

molecule that enables the formation of an extracellular biofilm matrix. However, it has

been shown to protect S. epidermidis from innate immune machinery, helping the

bacterium evade neutrophils, immunoglobulin and antimicrobial peptides [12]. Indeed,

this evolutionary arms race might still be underway. PNAG has been shown to have a

stimulatory effect on Toll-like Receptor 2 (TLR-2), a crucial receptor involved in the

activation of innate immune pathways [13]. The paradoxical implication of this is that

molecules that S. epidermidis uses to protect itself from the immune system are, in turn, a

trigger for the immune system. However, experiments utilizing genetic PNAG loss-of-

function mutants are required before contamination by substances with pro-inflammatory

properties can be definitively ruled out. Such contamination has commonly caused

researchers to observe TLR-2 stimulation [13,14].

Commensals and outer skin cells are also frequently in conversation to maintain

healthy immune function and well-being of the skin (Fig 4). Keratinocytes are involved

in the production of free fatty acids, molecules that are key compounds present in human

sebum and are, therefore, extremely common on human skin. Free fatty acids are

produced from the breakdown of lipids such as sebum triacylglycerides. Lipases

responsible for this breakdown come from commensals such as P. acnes and S.

Page 9: Zaidi_Capstone

Zaidi 9

epidermidis. Certain chain lengths of free fatty acids (C8-C12) have been shown to have

antimicrobial properties against a wide range of primarily gram-positive bacteria [11].

Keratinocytes are not the only cells taking part in innate immune function.

Commensal bacteria, especially gram-positive bacteria such as Streptococcus and

Streptomyces, produce their own cocktails of antimicrobial peptides to inhibit the growth

of other bacteria on the skin and maintain niche dominance [11]. Our knowledge of the

workings of these commensal antimicrobial peptides is limited to the few that have been

isolated and studied, such as Epidermin, Pep5 and epilancin K7, which are most

commonly characterized as compounds produced by S. epidermidis [15].

The modified proteins have a three-ringed structure containing regions that are

both hydrophobic and hydrophilic, enabling disruptive interactions with the microbial

membrane. Similar to the mechanisms by which classic (human) antimicrobial peptides

function, these disruptive interactions create pores in the microbial membrane which

prevent cells from maintaining the balance of their internal environments, cause cytosolic

leakage and can be lethal to the microbial cell [11].

Despite this, little work has been done on understanding these molecules.

Currently, there are no studies looking into the genes in S. epidermidis responsible for

encoding these commensal-derived antimicrobial peptides. However, with the scientific

community’s current keen interest in metagenomics and understanding the human

microbiome, it should not be long before such a study is conducted. Another future

directions that research will need to take before these mechanisms can be deduced are in

vivo studies of skin colonization and competition by knock-out S. epidermidis strains

lacking the ability to produce antimicrobial peptides.

Page 10: Zaidi_Capstone

Zaidi 10

Additionally, commensals such as S. epidermidis also enhance the innate activity

of keratinocytes. In vivo experiments have shown that S. epidermidis-conditioned culture

medium enhanced keratinocyte activity against potentially pathogenic bacteria by

activating the Toll-like receptor 2 of the keratinocyte. The conditioned culture medium

also enhanced keratinocyte activity against viruses – the keratinocytes were able to better

inhibit human papillomavirus 5 pseudovirus (artificial biological particles with

papillomavirus antigens on their surfaces) survival2 and prevent vaccinia virus plaque

formation in the keratinocyte monolayer [16].

Commensals are also frequently in conversation with the adaptive facet of the

human immune system. A recent murine study has shown that the function of effector or

helper T-cells in the skin is only effectively driven in the presence of resident bacteria

[17]. Helper T-cells steer the function of the immune system by producing and secreting

pro-inflammatory cytokines and are, thus, vital for a robust and balanced immune

response [18]. Commensal bacteria augment the signaling of the cytokine IL-2 in the skin

[17]. IL-2 plays a key role in the pathways that govern and regulate T-cell differentiation.

Therefore, the presence of commensal bacteria in the skin amplifies the local

inflammatory response and encourages T-cell differentiation into effector and memory

cells [17]. The study also found that mice that were raised germ-free generated little or no

memory against skin pathogens and had impaired development of Th17 cells, a subset of

effector T-cells specialized in antimicrobial immunity at epithelial and mucosal barriers.

During a subcutaneous infection of Leishmania major, the absence of S. epidermidis was

observed to have a negative effect on T-cell differentiation [17]. The exact mechanisms

2 Pseudovirus survival is measured based on the number of pseudoviral particles no destroyed or incapacitated by immune cells.

Page 11: Zaidi_Capstone

Zaidi 11

that enable S. epidermidis to play a role in immunoregulation are not well understood, nor

is it clear if S. epidermidis is the only commensal that exhibits the immunoregulatory

behavior we see, indicating that replication of these experiments using other common

skin commensals is required.

This evidence gathered so far establishes the benefits of a healthy skin

microbiome. It also provides clues behind mechanisms that may govern the pathogenesis

of inflammatory disorders of the skin.

IMMUNE DYSREGULATION

A number of skin conditions have been linked to immune disruption brought

about by non-normative skin microbiome community membership and behavior. These

include psoriasis, which is linked to unregulated Streptococcus activity; acne, which is

associated with Propionibacterium acnes; and dandruff, which is connected to increased

relative abundance of Malassezia fungus in the scalp. The etiologies of these conditions,

however, has not been thoroughly studied and is not well understood [19]. One condition

that is considered the most common manifestation of asynchrony between the

microbiome and the immune system is atopic dermatitis.

Atopic dermatitis, also known as eczema, is one of the most common chronic

inflammatory diseases of the skin [20]. It is also considered one of the most common

manifestations that result from an atypical skin microbiome. The prevalence of atopic

dermatitis has been increasing dramatically over the past few decades. Today, it is

estimated to have a lifetime prevalence of over 20%, primarily in high-income countries

[21]. Children are more likely to contract atopic dermatitis than adults. The International

Page 12: Zaidi_Capstone

Zaidi 12

Study of Asthma and Allergies in Childhood, an epidemiological study initiated in 1991

involving over two million children in more than 100 countries over the span of its three

phases, found that atopic dermatitis occurred in between 10 and 20 percent of children

worldwide, with higher prevalence in developed countries [21,22]. It is currently

uncertain why prevalence rates of atopic dermatitis are rising in this trend. The

phenomenon may be linked to the ‘hygiene hypothesis’, the idea that raising children in

an increasingly sterile environment is responsible for reducing immunogenic exposure to

antigens to a rate below that necessary for the regulation of normal immune function

[23].

The pathogenesis of atopic dermatitis includes skin barrier defects, immune

dysregulation and frequent and persistent infection [20]. Since this pathogenesis is a

complex interplay of genetic factors and environmental factors, the scientific community

has been unable to resolve the debate between two hypotheses that may explain it. The

‘outside-in hypothesis’ posits that the dysfunction and dysregulation of the epidermal

barrier is the primary insult, which leads to an immune response. The ‘inside-out

hypothesis’, on the other hand, argues that the disease is mainly driven by cytokines that

cause epidermal inflammation [20]. It is likely, however, that these two hypotheses are

not competing but actually play complicated and complementary roles in atopic

dermatitis.

Batista et al. performed an immunohistochemical study to observe the expression

of IL-17 as well as filaggrin and claudin 1 – skin barrier proteins that work to maintain

the structural integrity of the skin and also prevent transepidermal water loss – in skin

samples from atopic dermatitis patients. Lesional skin in adults with atopic dermatitis

Page 13: Zaidi_Capstone

Zaidi 13

was shown to have reduced expression of filaggrin and claudin 1 (see Fig 5) [24]. The

consequences of barrier defects are two-fold; it results in the release of cytokines IL-1a

and IL-1b, which are mediators in a complex inflammatory cytokine cascade that

encourages the leakage of inflammatory cells into the tissue, and contributes to a much

higher susceptibility to developing infections, particularly to Staphylococcus aureus [20].

By preventing uncontrolled water loss from the skin, filaggrin keeps the pH of the skin in

check [20]. Filaggrin is also crucial for the formation of natural moisturizing factor in the

skin [25]. Filaggrin deficiency or defects will therefore interfere with mechanisms that

maintain pH and moisture, making the landscape of the skin less hospitable to permanent

resident commensals. Consequently, these altered conditions could become optimal for

other microbial species that are usually not associated with the ‘normal’ skin

microbiome.

One such species is Staphylococcus aureus. In people without atopic dermatitis, S.

aureus is not a common skin commensal, usually out-competed and driven away by S.

epidermidis, which produces phenol-soluble modulins that specifically exert selective

antimicrobial action on the former [26]. Thus, when barrier defects in the skin make it

inhospitable to S. epidermidis, opportunistic colonization by S. aureus is facilitated. Over

90 percent of patients with atopic dermatitis have S. aureus colonies on their lesional skin

[3]. Therefore, colonization with S. aureus is considered to be an important factor for

atopic dermatitis pathogenesis.

To understand the role of S. aureus in the pathogenesis of atopic dermatitis,

Nakamura et al. performed a series of in vivo and in vitro experiments using mice and

murine samples (Fig 6A-C). The studies were driven by the hypothesis that δ-toxin

Page 14: Zaidi_Capstone

Zaidi 14

produced by S. aureus acts as a super-antigen that kicks the immune system into

overdrive, wreaking havoc among immune cells in the skin. The primary target of the

δ-toxin was believed to be mast cells, immune cells that produce and store pro-

inflammatory cytokines such as histamine in granules and that then degranulate to release

these cytokines into their local environment when stimulated. In the skin, mast cell

degranulation propagates Th2-type responses, resulting in local epidermal inflammation

[27], a common symptom of atopic dermatitis. Previously unstimulated mast cells were

introduced to δ-toxin derived from S. aureus and ionomycin, a known mediator of mast

cell degranulation. The results supported the hypothesis, showing that δ-toxin causes the

immediate degranulation of mast cells in culture, in a manner similar to that of

ionomycin. Application of δ-toxin directly onto murine skin also showed observable

worsening of disease state [28]. Furthermore, supernatant from cultures of a mutant strain

of S. aureus that lacked the ability to produce δ-toxin caused significantly reduced mast

cell stimulation when compared to the effect brought about by supernatant from cultured

wild-type S. aureus. Colonization of this mutant strain on murine skin was also

associated with a lower degree of mast cell degranulation and, thus, a better disease

status. [28]. This gold-standard study links the presence of δ-toxin producing S. aureus to

higher degrees of mast cell degranulation both in vivo and in vitro and also demonstrates

the consequent worsening of skin disease status in vivo. Replication of this study using

human mast cells for in vitro assays and human in vivo trials of S. aureus strain

colonization would further link the presence of the bacteria to skin inflammation and,

therefore, atopic dermatitis.

Increased S. aureus colonization has also been shown to adversely affect the

Page 15: Zaidi_Capstone

Zaidi 15

diversity of the microbiome which, in turn, is linked to a worsened disease status [29]. S.

aureus colonization significantly increases and microbiome diversity significantly suffers

during inflammation flares in people with atopic dermatitis [29]. Studies reaching this

conclusion have so far been unable to ascertain whether the observed decrease in

diversity is directly caused by S. aureus or if the defective skin barrier function is the

underlying mechanism that also mediates this. Investigation of murine skin microbiome

development in mice with barrier protein defects or deficiencies could be the first step

towards understanding this conundrum.

Interestingly, S. epidermidis is also observed to become more prevalent during

flares of inflammation which, given the antagonistic nature of S. epidermidis against S.

aureus, was not predicted [29]. However, it is hypothesized that the two Staphylococcus

species may engage in mutualistic relationships under certain conditions such as those of

atopic dermatitis, allowing S. epidermidis to ‘switch allegiances’ when it is conducive to

survival. This might manifest itself in the enhanced common resistance to antimicrobial

peptides [30]. Alternatively, the spikes in S. epidermidis could merely be a compensatory

flare during attempts to control and reign in S. aureus.

BARRIER REPAIR THERAPY

Currently, atopic dermatitis flares are treated by palliative management. This

involves both preventing flares by avoiding known triggers of the condition, regular

moisturizing and general skin care, as well as the reduction of flares with topical

application of corticosteroids [25].

Page 16: Zaidi_Capstone

Zaidi 16

Due to their association with the regulation of immune responses and

inflammation, corticosteriods have been used for over the past half-century as regular

treatment for atopic dermatitis; they have actually been shown to impair skin barrier

function by dehydrating the skin [31]. Keeping the skin hydrated by topically applying

moisturizers immediately after water absorption (such as after a shower) is crucial to the

management of the condition. Retained dermal water also increases the efficacy of

pharmacological molecules used to manage atopic dermatitis and reduces the dehydrating

effect of corticosterioids [25].

A study examining the diversity of the skin microbiome at base-line, mid-flare,

and post-treatment levels showed a significant decrease in microbiome diversity during

the flare and an increase in diversity after atopic dermatitis treatment began [29]. From

the perspective of the microbiome, atopic dermatitis treatments maintain the diversity of

the microbiome or help increase diversification after a flare by keeping transepidermal

moisture and pH at optimal levels. The lack of antimicrobial agents present in these

atopic dermatitis therapies suggest that the reduction in S. aureus colonization may,

instead, be caused by the return of the skin landscape to its normal form.

Despite this, due to the complex nature of atopic dermatitis, the scientific

community has not conclusively been able to determine whether or not these therapies

are efficacious against atopic dermatitis. Literature reviews seeking to answer this

question have cited studies with results that contradict each other and shown that most

studies are not scientifically rigorous enough due to small sample sizes and very narrow,

focused definitions of ‘efficacy’ (some studies, for example, overlooked clinical efficacy

and focused on the infiltration of inflammatory cells instead) [25].

Page 17: Zaidi_Capstone

Zaidi 17

THE BIG PICTURE

While much is still unknown about the host-commensal interactions with regards

to dermal immunity, it is clear that microbiome behaviour seems to be governed by the

integrity of the skin barrier function (Fig 7). In the absence of skin barrier defects, the

skin is more hospitable to commensals such as S. epidermidis, which seems to play a

protective role in immune regulation and modulation. However, when the skin barrier is

defective, the skin microbiome population changes for the worse. S. aureus becomes

more prevalent, which causes mast cell degranulation and local inflammation.

FUTURE DIRECTIONS

As we move from an age where non-human cells are indiscriminately seen as

foreign, non-self, harmful and, thus, to be eliminated to improve health outcomes to an

age where we have a better understanding of how the human body is an ecosystem

teeming with cells that are non-human but are neither foreign nor harmful, we have a lot

to learn about how our bodies react to and interact with our microbiomes and the role

these interactions play in health and disease.

With the rise of meta-“omics” technologies, there is a vast world of microbiomes

waiting to be explored. A deeper and more complex understanding of mechanisms that

keep us healthy or make us ill will provide entryways for more innovation. With regards

to the skin microbiome in particular, our improving understanding of the pathogenesis of

Page 18: Zaidi_Capstone

Zaidi 18

atopic dermatitis can lead to the development of new therapeutics such as those that block

δ -toxin production or supplement defective skin barrier proteins.

Page 19: Zaidi_Capstone

Zaidi 19

References

1. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486: 207-214.

2. Morgan XC, Segata N, Huttenhower C. Biodiversity and functional genomics in the human microbiome. Trends Genet. 2013;29: 51-58.

3. Baviera G, Leoni MC, Capra L, Cipriani F, Longo G, Maiello N, et al. Microbiota in healthy skin and in atopic eczema. Biomed Res Int. 2014;2014: 436921.

4. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9: 313-323.

5. Madison KC. Barrier function of the skin:“la raison d'etre” of the epidermis. J Invest Dermatol. 2003;121: 231-241.

6. Grice EA, Kong HH, Renaud G, Young AC, NISC Comparative Sequencing Program, Bouffard GG, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18: 1043-1050.

7. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107: 11971-11975.

8. Capone KA, Dowd SE, Stamatas GN, Nikolovski J. Diversity of the human skin microbiome early in life. J Invest Dermatol. 2011;131: 2026-2032.

9. University of Pennsylvania Perelman School of Medicine. Grice Lab Research Program. . 2015: 1. Available: http://www.med.upenn.edu/gricelab/research.shtml.

10. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9: 244-253.

11. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011;131: 1974-1980.

12. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 2004;6: 269-275.

13. Otto M. Staphylococcus epidermidis—the'accidental'pathogen. Nat Rev Microbiol. 2009;7: 555-567.

Page 20: Zaidi_Capstone

Zaidi 20

14. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol. 2006;177: 3162-3169.

15. Bastos M, Ceotto H, Coelho M, Nascimento J. Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Curr Pharm Biotechnol. 2009;10: 38-61.

16. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130: 2211-2221.

17. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, et al. Compartmentalized control of skin immunity by resident commensals. Science. 2012;337: 1115-1119.

18. Wan YY, Flavell RA. How diverse--CD4 effector T cells and their functions. J Mol Cell Biol. 2009;1: 20-36.

19. Hannigan GD, Grice EA. Microbial ecology of the skin in the era of metagenomics and molecular microbiology. Cold Spring Harb Perspect Med. 2013;3: a015362.

20. Czarnowicki T, Krueger JG, Guttman-Yassky E. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications. J Allergy Clin Immunol Pract. 2014;2: 371-9; quiz 380-1.

21. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014;69: 3-16.

22. Deckers IA, McLean S, Linssen S, Mommers M, Van Schayck C, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PloS one. 2012;7: e39803.

23. Prescott SL, Pawankar R, Allen KJ, Campbell DE, Sinn JK, Fiocchi A, et al. A global survey of changing patterns of food allergy burden in children. Allergy Organ J. 2013;6: 21.

24. Batista DI, Perez L, Orfali RL, Zaniboni MC, Samorano LP, Pereira NV, et al. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014.

25. Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol. 2013;14: 389-399.

Page 21: Zaidi_Capstone

Zaidi 21

26. Schommer NN, Gallo RL. Structure and function of the human skin microbiome. Trends Microbiol. 2013;21: 660-668.

27. Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014;14: 289-301.

28. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, Hasegawa M, et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503: 397-401.

29. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22: 850-859.

30. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 2001;193: 1067-1076.

31. Leung AK, Hon KE, Robson WLM. Atopic dermatitis. Adv Pediatr. 2007;1: 241-273.

Page 22: Zaidi_Capstone

Zaidi 22

FIGURE LEGENDS Fig 1: Simplified flow diagram highlighting key gene sequencing and bioinformatics techniques used for microbiome profiling. [Human Microbiome Project Consortium, 2012, Figure 1] Fig 2: Phylogenetic tree illustrating profiled human microbiome. In 2008, the National Institute of Health began the Human Microbiome Project. This five-year initiative characterized microorganisms associated with the human body, both healthy and diseased. The Project found a staggering array of microbial diversity in association with the human body, with 90% of cells in and on the body of non-human genetic origin. Despite this, the human microbiome is dominated by four main phyla: Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria. [Morgan et al. 2013, Figure 2] Fig 3: Commensal diversity of human skin varies by body site niche. Qualitative proportions of bacterial phyla found on various parts of the skin depends on characteristics of the skin: thickness, moisture levels, density of sebaceous glands, hair follicle density, and frequency of surface contact/exfoliation. [Grice & Segre, 2011, Figure 3] Fig 4: Relationship between skin cells and commensals for maintaining immune function. Both keratinocytes and skin commensals produce antimicrobial peptides that prevent skin infections. Commensal-derived lipases help break down sebum produced by sebaceous glands to form free fatty acids, which have been shown to have antimicrobial properties. The presence of commensal bacteria also directly enhances the innate immune function of keratinocytes. Fig 5: Atopic dermatitis skin samples express lower levels of skin barrier proteins. Immunohistochemical staining for filaggrin, claudins, and IL-17 was done on control (non-AD) and atopic dermatitis skin samples taken from volunteers via 4mm punch biopsy. The specimens were scanned and protein expression was calculated by determining the percentage of sample area positively stained. Counts of IL-17 positive cells were also taken. Control specimens had significantly higher expression of filaggrin and claudin 1, and significantly lower levels of IL-17 expression. AD status did not affect the expression levels of claudin 4. [Batista et al. 2014, Figure 1c] Fig 6: δ-toxin from S. aureus causes localized skin inflammation. A Electromicroscopic images of unstimulated murine mast cells (Cont), mast cells stimulated with δ-toxin and ionomycin, a known mast cell stimulant (positive control). Both ionomycin and δ-toxin caused mast cell degranulation. [Nakamura et al. 2013, Figure 1d] B Mice were colonized with wild-type S. aureus, ∆hld S. aureus (δ-toxin deficient mutant), or were treated with PBS (control). Colonization by wild-type S. aureus resulted in localized redness and epidermal disruption while both the control and ∆hld did not. [Nakamura et al. 2013, Figure 4c] C Number of neutrophils in skin after colonization

Page 23: Zaidi_Capstone

Zaidi 23

with wild-type S. aureus, ∆hld S. aureus, or after PBS treatment. Wild-type S. aureus colonization resulted in significant increase in epidermal neutrophil counts. Fig 7: Skin barrier integrity governs microbiome membership and skin health.

Page 24: Zaidi_Capstone

Zaidi 24

FIGURES Fig 1

Page 25: Zaidi_Capstone

Zaidi 25

Fig 2

Page 26: Zaidi_Capstone

Zaidi 26

Fig 3

Page 27: Zaidi_Capstone

Zaidi 27

Fig 4

COMMENSAL BACTERIA

KERATINOCYTES AND SEBACEOUS

GLANDS

AMPs FREE FATTY

ACIDS

Page 28: Zaidi_Capstone

Zaidi 28

Fig 5

Page 29: Zaidi_Capstone

Zaidi 29

Fig 6

Page 30: Zaidi_Capstone

Zaidi 30

Fig 7